#Amaris Clinical on #OVIS platform for Safe #ClinicalStudies
Amaris Clinical is a division of Caplin Point Laboratories; which is one of the fastest growing mid-cap pharmaceutical companies in India. The company holds over 2000 product licenses across the globe with a state of the art manufacturing facility for Injectables, already approved by EU-GMP, ANVISA and US-FDA.
Amaris Clinical, located in Chengalpattu in the southern state of TamilNadu in India, has deccided to avail the services of OVIS. This service offers nationa wide human voklunteers tracking to avoid Volunteers overdoing of drug. OVIS also offers risk free study environment.
#OVIS #ClinicalResearch #CRO #LifeScience #ClinicalStudy #HumanVolunteers #CleanVolunteers #LowRiskStudies #RiskFreeStudies #CrossParticipation #PhaseI #PhaseIII #EarlyStage #DrugTesting #ScreeningEligibility #DosingEligibility #RiskMitigation #HealthyVolunteers #LowCostStudies #SafeStudies #ADR #SADR #AvoidADR #DrugConcentration #RealTimeStatus #USFDA #CFR11 #BA #BE #PKStudies #InforcomTechnologies #NationalLevelSoftware #SaaS #ApplicationServiceProvider #APS #CovidSafety #CoronaScreening #CoronaTesting #CovidStudy #CovidTrial